Australia markets closed

BridgeBio Pharma, Inc. (BBIO)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
24.74-0.21 (-0.84%)
At close: 04:00PM EDT
24.88 +0.14 (+0.57%)
After hours: 05:34PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
9,303
9,303
77,648
69,716
8,249
Cost of revenue
2,446
2,446
3,434
3,114
0
Gross profit
6,857
6,857
74,214
66,602
8,249
Operating expenses
Research development
455,711
455,711
399,462
451,024
337,047
Selling general and administrative
150,590
150,590
143,189
192,210
145,684
Total operating expenses
606,301
606,301
542,651
643,234
482,731
Operating income or loss
-599,444
-599,444
-468,437
-576,632
-474,482
Interest expense
81,289
81,289
80,438
46,778
36,655
Total other income/expenses net
9,444
9,444
56,681
35,823
1,634
Income before tax
-653,251
-653,251
-484,652
-586,454
-505,488
Income from continuing operations
-653,251
-653,251
-484,652
-586,454
-505,488
Net income
-643,202
-643,202
-481,183
-562,539
-448,724
Net income available to common shareholders
-643,202
-643,202
-481,183
-562,539
-448,724
Basic EPS
-3.91
-
-3.26
-3.90
-3.80
Diluted EPS
-3.91
-
-3.26
-3.90
-3.80
Basic average shares
156,510
-
147,473
144,357
117,995
Diluted average shares
156,510
-
147,473
144,357
117,995